Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 85.55 USD 0.14% Market Closed
Market Cap: 4.3B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Income Statement

Earnings Waterfall
Haemonetics Corp

Revenue
1.4B USD
Cost of Revenue
-625.9m USD
Gross Profit
735.3m USD
Operating Expenses
-520.2m USD
Operating Income
215m USD
Other Expenses
-91.2m USD
Net Income
123.8m USD

Income Statement
Haemonetics Corp

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Apr-2016 Jul-2016 Oct-2016 Dec-2016 Apr-2017 Jul-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Dec-2022 Apr-2023 Jul-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
935
N/A
925
-1%
910
-2%
899
-1%
891
-1%
893
+0%
909
+2%
905
0%
906
+0%
900
-1%
886
-2%
887
+0%
892
+1%
899
+1%
904
+1%
922
+2%
939
+2%
952
+1%
968
+2%
977
+1%
988
+1%
999
+1%
989
-1%
946
-4%
903
-5%
884
-2%
871
-2%
903
+4%
934
+3%
953
+2%
993
+4%
1 026
+3%
1 084
+6%
1 129
+4%
1 169
+3%
1 219
+4%
1 239
+2%
1 270
+2%
1 309
+3%
1 334
+2%
1 361
+2%
Gross Profit
Cost of Revenue
(484)
(484)
(476)
(469)
(464)
(468)
(503)
(511)
(513)
(515)
(508)
(508)
(513)
(509)
(492)
(498)
(507)
(520)
(529)
(527)
(522)
(517)
(501)
(486)
(465)
(454)
(463)
(486)
(499)
(500)
(468)
(487)
(509)
(534)
(546)
(578)
(586)
(591)
(600)
(619)
(626)
Gross Profit
451
N/A
442
-2%
434
-2%
431
-1%
428
-1%
425
-1%
406
-5%
395
-3%
393
0%
386
-2%
379
-2%
379
+0%
380
+0%
390
+3%
412
+6%
425
+3%
432
+2%
432
0%
439
+2%
450
+3%
465
+3%
482
+4%
488
+1%
459
-6%
438
-5%
430
-2%
408
-5%
418
+3%
435
+4%
454
+4%
526
+16%
540
+3%
575
+7%
595
+4%
623
+5%
640
+3%
653
+2%
679
+4%
709
+4%
715
+1%
735
+3%
Operating Income
Operating Expenses
(362)
(356)
(331)
(385)
(375)
(352)
(362)
(450)
(443)
(345)
(339)
(314)
(309)
(309)
(312)
(314)
(323)
(325)
(320)
(323)
(312)
(308)
(314)
(314)
(320)
(324)
(334)
(357)
(375)
(394)
(425)
(420)
(434)
(449)
(455)
(458)
(469)
(480)
(495)
(509)
(520)
Selling, General & Administrative
(299)
(288)
(259)
(278)
(287)
(300)
(317)
(317)
(314)
(306)
(302)
(280)
(276)
(271)
(273)
(274)
(281)
(287)
(285)
(289)
(279)
(277)
(284)
(283)
(290)
(294)
(269)
(274)
(277)
(281)
(332)
(331)
(349)
(365)
(373)
(374)
(385)
(396)
(411)
(416)
(419)
Research & Development
(48)
(46)
(43)
(42)
(44)
(45)
(45)
(45)
(42)
(39)
(38)
(34)
(34)
(37)
(39)
(40)
(42)
(38)
(36)
(34)
(33)
(31)
(30)
(31)
(30)
(31)
(32)
(38)
(42)
(44)
(46)
(45)
(45)
(48)
(49)
(52)
(54)
(54)
(52)
(56)
(60)
Depreciation & Amortization
(15)
(23)
(30)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(33)
(45)
(57)
(69)
(47)
(44)
(40)
(36)
(33)
(32)
(31)
(30)
(32)
(37)
(42)
Other Operating Expenses
0
0
0
(65)
(45)
(7)
0
(88)
(88)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
89
N/A
85
-4%
103
+21%
46
-56%
53
+15%
73
+39%
44
-40%
(56)
N/A
(50)
+10%
40
N/A
39
-2%
65
+66%
70
+7%
81
+16%
100
+23%
111
+11%
109
-1%
107
-2%
118
+11%
127
+7%
154
+21%
175
+14%
174
0%
145
-17%
117
-19%
105
-10%
74
-30%
61
-17%
60
-2%
59
-1%
101
+70%
120
+19%
141
+17%
146
+4%
168
+15%
182
+8%
184
+1%
199
+8%
213
+7%
206
-4%
215
+5%
Pre-Tax Income
Interest Income Expense
(10)
(9)
(9)
(9)
(9)
(9)
(10)
(10)
(9)
(9)
(8)
(7)
(7)
(5)
(5)
(5)
(7)
(9)
(10)
(12)
(14)
(14)
(16)
(16)
(15)
(15)
(17)
(18)
(18)
(20)
(17)
(18)
(19)
(16)
(15)
(12)
(8)
(9)
(13)
(4)
(9)
Non-Reccuring Items
(49)
(45)
(63)
0
0
(100)
(88)
0
0
(8)
(59)
(52)
(57)
(89)
(36)
(66)
(63)
(33)
(35)
(62)
(65)
(74)
(71)
(17)
20
32
16
18
(15)
(19)
(20)
(10)
(8)
(6)
(12)
(3)
(16)
(29)
(48)
(55)
(48)
Pre-Tax Income
30
N/A
31
+3%
31
-1%
37
+19%
44
+18%
(35)
N/A
(53)
-51%
(65)
-22%
(59)
+10%
23
N/A
(28)
N/A
6
N/A
6
+2%
(13)
N/A
60
N/A
40
-33%
40
+0%
65
+64%
74
+13%
53
-29%
75
+42%
87
+16%
87
+0%
113
+29%
123
+9%
122
0%
73
-40%
62
-15%
27
-57%
21
-22%
64
+204%
92
+45%
113
+23%
124
+10%
141
+14%
168
+18%
159
-5%
161
+1%
152
-6%
147
-3%
159
+8%
Net Income
Tax Provision
0
(1)
(14)
(17)
(18)
(14)
(2)
(1)
0
(7)
1
(2)
(1)
23
14
11
9
(19)
(19)
(3)
(7)
(7)
(11)
(17)
(17)
(14)
7
3
4
2
(20)
(25)
(27)
(28)
(26)
(31)
(31)
(34)
(34)
(32)
(35)
Income from Continuing Operations
30
30
17
20
26
(50)
(56)
(66)
(59)
16
(26)
4
5
11
73
51
49
46
55
49
68
80
77
96
106
108
80
65
31
23
43
68
86
96
115
137
128
127
118
115
124
Net Income (Common)
30
N/A
30
-1%
17
-44%
20
+20%
26
+27%
(50)
N/A
(56)
-12%
(66)
-18%
(59)
+11%
16
N/A
(26)
N/A
4
N/A
5
+7%
(17)
N/A
46
N/A
23
-50%
21
-6%
46
+116%
55
+19%
49
-10%
68
+38%
80
+17%
77
-4%
96
+25%
106
+11%
108
+2%
80
-26%
65
-19%
31
-51%
23
-28%
43
+92%
68
+56%
86
+27%
96
+11%
115
+21%
137
+18%
128
-6%
127
-1%
118
-7%
115
-2%
124
+8%
EPS (Diluted)
0.57
N/A
0.57
N/A
0.32
-44%
0.38
+19%
0.49
+29%
-0.99
N/A
-1.09
-10%
-1.29
-18%
-1.13
+12%
0.31
N/A
-0.51
N/A
0.08
N/A
0.08
N/A
-0.32
N/A
0.85
N/A
0.43
-49%
0.4
-7%
0.86
+115%
1.04
+21%
0.96
-8%
1.3
+35%
1.53
+18%
1.48
-3%
1.85
+25%
2.07
+12%
2.11
+2%
1.55
-27%
1.25
-19%
0.6
-52%
0.43
-28%
0.84
+95%
1.31
+56%
1.66
+27%
1.85
+11%
2.24
+21%
2.66
+19%
2.5
-6%
2.47
-1%
2.29
-7%
2.23
-3%
2.41
+8%

See Also

Discover More